Eines der meist diskutierten Themen, nicht nur an der Börse, sondern auch im Alltag, war in den letzten zwei Monaten die Künstliche Intelligenz (KI), angetrieben durch ChatGPT.
Key PointsChristopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his companys common stock.The CEO of Recursion Pharmaceuticals...
Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) were sinking 8.2% lower as of 10:57 a.m. ET on Monday. The clinical-stage biotech company, which is a pioneer in using artificial...
Machine-learning techniques keep improving efficiency in one industry after another. One corner of the economy where investors expect another big leap forward is the world...
Everything touching artificial intelligence (AI) is hot right now, so its no surprise that the biotech Recursion Pharmaceuticals (NASDAQ: RXRX) could be positioned to ride...
